SCHEDULE 13G/A: BlackRock Discloses 8.5% Stake in Cencora, Inc. via Latest SEC Filing
Beneficial Ownership Disclosure
BlackRock, Inc. has filed an amended Schedule 13G, revealing its beneficial ownership of 8.5% of Cencora, Inc.'s common stock as of December 31, 2024.
Summary
- BlackRock, Inc. reported beneficial ownership of 16,405,771 shares of Cencora, Inc. common stock.
- This represents 8.5% of Cencora, Inc.'s total outstanding common stock.
- BlackRock holds sole voting power over 15,013,416 shares and sole dispositive power over 16,405,771 shares.
- The filing is an Amendment No. 16 to Schedule 13G, indicating a routine update to a previously disclosed position.
- BlackRock certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Cencora, Inc.
- The filing was made by BlackRock as a parent holding company, with various subsidiaries contributing to the aggregate beneficial ownership, including Aperio Group, LLC, which beneficially owns 5% or greater of the outstanding shares.
Sentiment
Score: 5
Explanation: The document is a routine ownership disclosure (Schedule 13G) and does not contain information that would significantly alter the sentiment towards Cencora, Inc. It indicates a stable, passive investment by a major institutional holder.
Positives
- BlackRock, a major institutional investor, maintaining a significant stake (8.5%) in Cencora, Inc. could be interpreted as a continued vote of confidence in the company.
- The filing explicitly states that BlackRock's ownership is for investment purposes in the ordinary course of business and not for control, suggesting stability in the ownership structure and no immediate activist intentions.
Future Outlook
NA
Industry Context
This filing reflects a routine disclosure by a major asset manager, BlackRock, regarding its passive investment stake in Cencora, Inc. It does not provide specific insights into Cencora's operational performance or broader industry trends, but rather indicates continued institutional interest in the pharmaceutical distribution and healthcare solutions sector where Cencora operates.
Stakeholder Impact
- Shareholders: Provides transparency on a significant institutional shareholder's stake, which can offer some stability or confidence regarding the company's ownership structure.
Key Dates
| Date | Description |
|---|---|
| 2023-04-30 | Date of previous Power of Attorney that was revoked by the new one. |
| 2024-12-31 | Date of event which requires filing of this statement (reporting period end date for the ownership stake). |
| 2025-01-21 | Date of execution of the new Power of Attorney for BlackRock, Inc. |
| 2025-01-31 | Date of signing the Schedule 13G filing. |
Keywords
Cencora Inc, BlackRock Inc, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, SEC Filing, Shareholding, Investment Management
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.